Balance Sheet Data
Adamas Pharmaceuticals, Inc. (ADMS)
$8.22
0.00 (0.00%)
Year A/P | 2016 Actual | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Projected | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected |
| Total Cash | 113.65 | 173.44 | 210.87 | 132.61 | 83.36 | 121,261.01 | 1,927,780.22 | 30,647,416.79 | 487,225,745.01 | 7,745,805,404.73 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 0.96 | 1.37 | 6.35 | 7.03 | 9.29 | 1,072.05 | 17,043.18 | 270,948.58 | 4,307,479.66 | 68,479,343.66 |
| Account Receivables (%) | ||||||||||
| Inventories | - | 1.70 | 5.12 | 5.27 | 7.29 | 985.19 | 15,662.34 | 248,996.35 | 3,958,487.95 | 62,931,151.82 |
| Inventories (%) | ||||||||||
| Accounts Payable | 3.59 | 3.88 | 6.57 | 6.93 | 2.14 | 3,175.97 | 50,490.87 | 802,692.56 | 12,761,025.88 | 202,871,921.83 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -1.62 | -1.26 | -1.06 | -0.02 | -94.45 | -1,501.57 | -23,871.68 | -379,506.63 | -6,033,311.12 | -95,916,224.31 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.